Catalyst Wire Dossier Catalyst Wire Dossier

Symtuza

darunavir/cobicistat/emtricitabine/tenofovir alafenamide · Janssen Pharmaceuticals
Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for Symtuza, covering 2017-10-17 to 2025-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Healthy Participants to Assess the Effect of Darunavir, Emtricitabine, and Tenofovir Alafenamide in the Presence of Cobicistat as Fixed Dose Combination (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) Compared With Co-administration of the Separate Agents [Phase 1]

See pricing